Last reviewed · How we verify
IPTc+CCM
IPTc+CCM combines intermittent preventive treatment with community case management to reduce malaria transmission and clinical disease in endemic populations.
IPTc+CCM combines intermittent preventive treatment with community case management to reduce malaria transmission and clinical disease in endemic populations. Used for Malaria prevention and case management in children in endemic regions.
At a glance
| Generic name | IPTc+CCM |
|---|---|
| Sponsor | Cheikh Anta Diop University, Senegal |
| Modality | Small molecule |
| Therapeutic area | Infectious Disease |
| Phase | Phase 3 |
Mechanism of action
IPTc (Intermittent Preventive Treatment in children) involves periodic antimalarial drug administration to prevent malaria infection, while CCM (Community Case Management) enables rapid diagnosis and treatment of malaria cases at the community level. Together, this integrated approach targets both prevention through chemoprophylaxis and prompt case management to reduce overall malaria burden.
Approved indications
- Malaria prevention and case management in children in endemic regions
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IPTc+CCM CI brief — competitive landscape report
- IPTc+CCM updates RSS · CI watch RSS
- Cheikh Anta Diop University, Senegal portfolio CI